Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma

Title
Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma
Authors
Keywords
-
Journal
Journal of Cancer
Volume 7, Issue 15, Pages 2280-2289
Publisher
Ivyspring International Publisher
Online
2016-12-29
DOI
10.7150/jca.15758

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now